Natco Pharma Ltd.
BSE: 524816 | Sector: Health care |
NSE: NATCOPHARM | ISIN Code: INE987B01026 |
BSE 00:00 | 26 Feb | 812.60 |
10.40 (1.30%) |
OPEN
815.00 |
HIGH
820.00 |
LOW
795.10 |
NSE 00:00 | 26 Feb | 811.35 |
9.05 (1.13%) |
OPEN
803.55 |
HIGH
820.00 |
LOW
793.20 |
OPEN | 815.00 |
PREVIOUS CLOSE | 802.20 |
VOLUME | 24501 |
52-Week high | 995.05 |
52-Week low | 450.00 |
P/E | 41.93 |
Mkt Cap.(Rs cr) | 14,818 |
Buy Price | 809.00 |
Buy Qty | 4.00 |
Sell Price | 812.60 |
Sell Qty | 5.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Natco Pharma Ltd. (NATCOPHARM) - Nine Monthly Result
Particulars (![]() |
Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 |
Net Sales/Income From Operations | 1342.00 | 1370.10 | 1570.00 | 1362.30 | 1415.80 |
Other Income | 72.00 | 85.20 | 99.10 | 18.80 | 14.00 |
Total Income | 1414.00 | 1455.30 | 1669.10 | 1381.10 | 1429.80 |
Total Expenditure | 1000.80 | 910.70 | 903.70 | 810.20 | 965.10 |
Operating Profit | 413.20 | 544.60 | 765.40 | 570.90 | 464.70 |
Interest | 9.00 | 17.10 | 13.60 | 12.00 | 11.60 |
Gross Profit | 404.20 | 527.50 | 751.80 | 558.90 | 453.10 |
Depreciation | 85.40 | 68.30 | 58.80 | 47.70 | 40.40 |
PBT | 318.80 | 459.20 | 693.00 | 511.20 | 412.70 |
Tax | 69.00 | 103.50 | 170.30 | 109.10 | 89.40 |
Net Profit/(Loss) | 252.30 | 373.50 | 543.70 | 402.10 | 317.50 |
Minority Interest After NP | - | - | - | - | - |
Net Profit after Minority Interest | - | - | - | - | - |
Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Profit After Exceptional Items | 252.30 | 373.50 | 543.70 | 402.10 | 317.50 |
Equity Share Capital | 36.40 | 36.40 | 36.80 | 36.90 | 34.90 |
Reserves Excluding Revaluation Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EPS | |||||
Basic EPS | 13.85 | 20.53 | 29.47 | 22.94 | 18.14 |
Public Share Holding | |||||
No Of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
Share Holding (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Promoters and Promoter Group Shareholding | |||||
a) Pledged/Encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of Shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of Shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
b) Non-encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Note : | PBT include deferred tax and fringe benefit tax Net profit figures include extra-ordinary items income/expenditure. |
Quick Links for Natco Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices